Auro Laboratories Limited (AUROLAB.BO)
INR 279.85
(-0.09%)
INR 279.85
(-0.09%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 252.51 Million INR | 445.84% |
| 2022 | 46.26 Million INR | -45.99% |
| 2021 | 85.65 Million INR | 211.79% |
| 2020 | -76.62 Million INR | -1172.75% |
| 2019 | 7.14 Million INR | -84.92% |
| 2018 | 47.35 Million INR | -36.02% |
| 2017 | 74 Million INR | 66.87% |
| 2016 | 44.35 Million INR | -38.23% |
| 2015 | 71.8 Million INR | -56.21% |
| 2014 | 163.96 Million INR | 17.73% |
| 2013 | 139.27 Million INR | -17.0% |
| 2012 | 167.79 Million INR | 12.64% |
| 2011 | 148.97 Million INR | 19.53% |
| 2010 | 124.63 Million INR | 22.79% |
| 2009 | 101.5 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | 17.87 Million INR | -61.37% |
| 2023 FY | 252.51 Million INR | 445.84% |
| 2023 Q3 | 69.77 Million INR | -22.38% |
| 2023 Q4 | 252.51 Million INR | 261.91% |
| 2023 Q2 | 89.89 Million INR | 402.99% |
| 2022 FY | 46.26 Million INR | -45.99% |
| 2022 Q4 | 46.26 Million INR | -17.78% |
| 2022 Q3 | 56.26 Million INR | 44.64% |
| 2022 Q2 | 38.9 Million INR | -25.36% |
| 2022 Q1 | 52.11 Million INR | -39.16% |
| 2021 Q4 | 85.65 Million INR | -51.07% |
| 2021 Q3 | 175.04 Million INR | 771.35% |
| 2021 Q1 | 145.36 Million INR | 289.7% |
| 2021 Q2 | -26.07 Million INR | -117.94% |
| 2021 FY | 85.65 Million INR | 211.79% |
| 2020 Q1 | 56.84 Million INR | 695.76% |
| 2020 Q4 | -76.62 Million INR | -191.63% |
| 2020 Q2 | -14.51 Million INR | -125.53% |
| 2020 Q3 | 83.62 Million INR | 676.15% |
| 2020 FY | -76.62 Million INR | -1172.75% |
| 2019 Q3 | 80.83 Million INR | 635.51% |
| 2019 FY | 7.14 Million INR | -84.92% |
| 2019 Q2 | -15.09 Million INR | -122.08% |
| 2019 Q1 | 68.36 Million INR | 44.37% |
| 2019 Q4 | 7.14 Million INR | -91.16% |
| 2018 Q2 | 70.09 Million INR | 289.96% |
| 2018 Q4 | 47.35 Million INR | 2.42% |
| 2018 FY | 47.35 Million INR | -36.02% |
| 2018 Q3 | 46.23 Million INR | -34.04% |
| 2018 Q1 | 17.97 Million INR | -75.71% |
| 2017 Q1 | 10.05 Million INR | -77.34% |
| 2017 Q4 | 74 Million INR | 2.69% |
| 2017 FY | 74 Million INR | 66.87% |
| 2017 Q3 | 72.06 Million INR | 49.07% |
| 2017 Q2 | 48.34 Million INR | 380.93% |
| 2016 Q1 | 5.32 Million INR | -92.59% |
| 2016 FY | 44.35 Million INR | -38.23% |
| 2016 Q4 | 44.35 Million INR | 138.53% |
| 2016 Q3 | 18.59 Million INR | -39.85% |
| 2016 Q2 | 30.91 Million INR | 481.03% |
| 2015 Q4 | 71.8 Million INR | 43953.33% |
| 2015 Q3 | 163 Thousand INR | -99.81% |
| 2015 Q2 | 86.18 Million INR | 1871.72% |
| 2015 Q1 | 4.37 Million INR | -97.33% |
| 2015 FY | 71.8 Million INR | -56.21% |
| 2014 Q4 | 163.96 Million INR | 17957.82% |
| 2014 Q3 | 908 Thousand INR | -98.93% |
| 2014 Q2 | 84.98 Million INR | 500.24% |
| 2014 Q1 | 14.15 Million INR | -89.83% |
| 2014 FY | 163.96 Million INR | 17.73% |
| 2013 Q1 | 41.91 Million INR | -75.02% |
| 2013 FY | 139.27 Million INR | -17.0% |
| 2013 Q2 | 51.68 Million INR | 23.31% |
| 2013 Q3 | 6.8 Million INR | -86.83% |
| 2013 Q4 | 139.27 Million INR | 1946.97% |
| 2012 Q3 | 68.71 Million INR | 0.0% |
| 2012 FY | 167.79 Million INR | 12.64% |
| 2012 Q4 | 167.79 Million INR | 144.18% |
| 2011 Q4 | 148.97 Million INR | 0.0% |
| 2011 FY | 148.97 Million INR | 19.53% |
| 2010 FY | 124.63 Million INR | 22.79% |
| 2010 Q4 | 124.63 Million INR | 0.0% |
| 2009 FY | 101.5 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.21 Million INR | -901.517% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 41.51% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 665.875% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 431.59% |
| Sunil Healthcare Limited | 625.4 Million INR | 59.624% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 4268.306% |
| MedPlus Health Services Limited | 8.67 Billion INR | 97.09% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 63.371% |
| Patidar Buildcon Limited | 25.12 Million INR | -904.999% |
| Roopa Industries Limited | 216.01 Million INR | -16.897% |
| Smruthi Organics Limited | 111.28 Million INR | -126.901% |
| Trident Lifeline Limited | 117.56 Million INR | -114.798% |
| PANJON LTD. | -12.8 Million INR | 2071.549% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -577.204% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -568.669% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -1778.141% |
| Anuh Pharma Limited | -69.8 Million INR | 461.734% |
| Crestchem Limited | -1.45 Million INR | 17514.897% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 515.787% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 2309.239% |
| Tyche Industries Limited | -788.94 Million INR | 132.007% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 75.813% |
| Trimurthi Limited | -1.17 Million INR | 21532.354% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 469.906% |
| Norris Medicines Limited | 214.86 Million INR | -17.525% |
| Zenlabs Ethica Limited | 139.54 Million INR | -80.955% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -553.763% |
| ANG Lifesciences India Limited | 671.01 Million INR | 62.368% |
| Parmax Pharma Limited | 51.8 Million INR | -387.389% |
| Veerhealth Care Limited | -2.38 Million INR | 10687.673% |
| Deccan Health Care Limited | -7.07 Million INR | 3668.626% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 75.881% |
| Makers Laboratories Limited | 172.59 Million INR | -46.309% |
| Lactose (India) Limited | 373.97 Million INR | 32.477% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 55.802% |
| Zenith Healthcare Limited | -25.45 Million INR | 1091.931% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 393.794% |
| Bacil Pharma Limited | 569 Thousand INR | -44278.91% |
| PRAVEG LIMITED | -434.98 Million INR | 158.051% |
| Denis Chem Lab Limited | -236.28 Million INR | 206.869% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 72.605% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 131.887% |
| Colinz Laboratories Limited | -64.3 Million INR | 492.697% |
| Godavari Drugs Limited | 530.02 Million INR | 52.357% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 2812.309% |
| Zenotech Laboratories Limited | -196.85 Million INR | 228.274% |
| Panchsheel Organics Limited | -157.82 Million INR | 260.002% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | -25.096% |
| Vivanza Biosciences Limited | 50.02 Million INR | -404.77% |
| Phaarmasia Limited | -4.89 Million INR | 5256.545% |
| Sastasundar Ventures Limited | -297.24 Million INR | 184.951% |
| Medi-Caps Limited | -3.21 Million INR | 7956.752% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 371.12% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 568.629% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | -91.155% |
| Mercury Laboratories Limited | -26.72 Million INR | 1044.727% |
| Gennex Laboratories Limited | -552.54 Million INR | 145.701% |
| BDH Industries Limited | -164.47 Million INR | 253.533% |
| Coral Laboratories Limited | -612.82 Million INR | 141.205% |
| Concord Drugs Limited | 164.48 Million INR | -53.517% |
| Bharat Parenterals Limited | 1.48 Billion INR | 83.038% |
| Beryl Drugs Limited | 48.7 Million INR | -418.428% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | -220.843% |
| Evoq Remedies Limited | 41.14 Million INR | -513.677% |
| Add-Shop E-Retail Limited | 116.24 Million INR | -117.222% |
| Transchem Limited | -3.16 Million INR | 8083.433% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 625.003% |
| Parnax Lab Limited | 787.61 Million INR | 67.939% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 531.018% |
| Kerala Ayurveda Limited | 447.82 Million INR | 43.613% |
| Cian Healthcare Limited | 544.97 Million INR | 53.664% |
| Trinity League India Limited | -12 Thousand INR | 2104400.0% |
| Syschem (India) Limited | 3.53 Million INR | -7049.377% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 81.9% |
| Natural Capsules Limited | 956.68 Million INR | 73.605% |